Tilray Brands, Inc. Goodwill, Foreign Currency Translation Gain (Loss)
Tilray Brands, Inc. (TLRY) reported Goodwill, Foreign Currency Translation Gain (Loss) of $2.21 million for the 9-month period ending 2023-02-28, per its 10-Q filed 2023-04-10.
Discontinued › Income Statement › Other Income
us-gaap:GoodwillForeignCurrencyTranslationGainLoss · last filed 2023-04-10
- Tilray Brands, Inc. goodwill, foreign currency translation gain (loss) for the quarter ending 2023-02-28 was $81.00K, a 98.66% decline year-over-year.
- Tilray Brands, Inc. goodwill, foreign currency translation gain (loss) for the quarter ending 2022-11-30 was -$13.90M.
- Tilray Brands, Inc. goodwill, foreign currency translation gain (loss) for the quarter ending 2022-08-31 was $16.03M, a 59.97% decline year-over-year.
- Tilray Brands, Inc. goodwill, foreign currency translation gain (loss) for the quarter ending 2022-05-31 was -$180.00K.
- Tilray Brands, Inc. goodwill, foreign currency translation gain (loss) for fiscal 2021 was $63.71M.
- Tilray Brands, Inc. goodwill, foreign currency translation gain (loss) for fiscal 2020 was $3.66M.
- Tilray Brands, Inc. goodwill, foreign currency translation gain (loss) for fiscal 2020 was $64.00K.
- Tilray Brands, Inc. goodwill, foreign currency translation gain (loss) for fiscal 2019 was $2.12M.
| Period end | Goodwill, Foreign Currency Translation Gain (Loss) 3 month | Goodwill, Foreign Currency Translation Gain (Loss) 6 month | Goodwill, Foreign Currency Translation Gain (Loss) 9 month | Goodwill, Foreign Currency Translation Gain (Loss) 12 month |
|---|---|---|---|---|
| 2023-02-28 | $81.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-04-10 | -$13.82M derived: sum of 2 quarters · filed 2023-04-10 | $2.21M 10-Q · filed 2023-04-10 | $2.03M derived: sum of 4 quarters · filed 2023-04-10 |
| 2022-11-30 | -$13.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-01-09 | $2.13M 10-Q · filed 2023-01-09 | $1.95M derived: sum of 3 quarters · filed 2023-04-10 | $8.02M derived: sum of 4 quarters · filed 2023-04-10 |
| 2022-08-31 | $16.03M 10-Q · filed 2022-10-07 | $15.85M derived: sum of 2 quarters · filed 2023-04-10 | $21.92M derived: sum of 3 quarters · filed 2023-04-10 | $15.62M derived: sum of 4 quarters · filed 2023-04-10 |
| 2022-05-31 | -$180.00K derived: 10-Q 12 month − 10-Q 9 month · filed 2023-04-10 | $5.89M derived: sum of 2 quarters · filed 2023-04-10 | -$410.00K derived: sum of 3 quarters · filed 2023-04-10 | $39.64M 10-Q · filed 2023-04-10 |
| 2022-02-28 | $6.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-04-06 | -$230.00K derived: sum of 2 quarters · filed 2022-04-06 | $39.82M 10-Q · filed 2022-04-06 | |
| 2021-11-30 | -$6.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-01-10 | $33.75M 10-Q · filed 2022-01-10 | ||
| 2021-08-31 | $40.05M 10-Q · filed 2021-10-07 | |||
| 2021-05-31 | $63.71M 10-K · filed 2022-07-28 | |||
| 2021-03-31 | $2.16M 10-Q · filed 2021-05-10 | $9.48M derived: sum of 2 quarters · filed 2021-05-10 | $12.71M derived: sum of 3 quarters · filed 2021-05-10 | $18.21M derived: sum of 4 quarters · filed 2021-05-10 |
| 2020-12-31 | $7.32M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-19 | $10.54M derived: sum of 2 quarters · filed 2021-02-19 | $16.05M derived: sum of 3 quarters · filed 2021-02-19 | $3.66M 10-K · filed 2021-02-19 |
| 2020-09-30 | $3.22M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $8.72M derived: sum of 2 quarters · filed 2020-11-09 | -$3.66M 10-Q · filed 2020-11-09 | -$1.02M derived: sum of 4 quarters · filed 2020-11-09 |
| 2020-06-30 | $5.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | -$6.88M 10-Q · filed 2020-08-10 | -$4.25M derived: sum of 3 quarters · filed 2020-08-10 | -$7.20M derived: sum of 4 quarters · filed 2020-08-10 |
| 2020-05-31 | $64.00K 10-K · filed 2021-07-28 | |||
| 2020-03-31 | -$12.38M 10-Q · filed 2020-05-11 | -$9.75M derived: sum of 2 quarters · filed 2020-05-11 | -$12.70M derived: sum of 3 quarters · filed 2020-05-11 | |
| 2019-12-31 | $2.63M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | -$319.00K derived: sum of 2 quarters · filed 2020-03-02 | $2.12M 10-K · filed 2020-03-02 | |
| 2019-09-30 | -$2.95M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13 | -$508.00K 10-Q · filed 2019-11-13 | ||
| 2019-06-30 | $2.44M 10-Q · filed 2019-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |